Open | $1.410 |
Close | $1.490 |
Volume / Avg. | 9.029M / 3.136M |
Day Range | 1.380 - 1.520 |
52 Wk Range | 1.250 - 2.360 |
Market Cap | $389.311M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | % |
Days to Cover | 3.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of SNDL (NASDAQ: SNDL) through any online brokerage.
Other companies in SNDL’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and Xeris Biopharma Holdings (NASDAQ:XERS).
The latest price target for SNDL (NASDAQ: SNDL) was reported by Cantor Fitzgerald on Monday, November 28, 2022. The analyst firm set a price target for 3.60 expecting SNDL to rise to within 12 months (a possible 141.63% upside). 0 analyst firms have reported ratings in the last year.
The stock price for SNDL (NASDAQ: SNDL) is $1.4899 last updated March 18, 2024 at 7:54 PM EDT.
There are no upcoming dividends for SNDL.
SNDL’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for SNDL.
SNDL is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.